F. Clémente

688 total citations
32 papers, 588 citations indexed

About

F. Clémente is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, F. Clémente has authored 32 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 15 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in F. Clémente's work include Pancreatic function and diabetes (13 papers), Fibroblast Growth Factor Research (6 papers) and Neuropeptides and Animal Physiology (6 papers). F. Clémente is often cited by papers focused on Pancreatic function and diabetes (13 papers), Fibroblast Growth Factor Research (6 papers) and Neuropeptides and Animal Physiology (6 papers). F. Clémente collaborates with scholars based in France, United States and Italy. F. Clémente's co-authors include A. Estival, A Ribet, Catherine Figarella, Nicole Vaysse, Jacopo Meldolesi, E Hollande, Odette Guy, Lucien Pradayrol, Alain De and Pascal Clerc and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and The Journal of Physiology.

In The Last Decade

F. Clémente

32 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Clémente France 16 288 239 130 106 105 32 588
Odette Morin Canada 12 281 1.0× 201 0.8× 71 0.5× 55 0.5× 157 1.5× 22 681
J.L. Scemama France 14 298 1.0× 160 0.7× 123 0.9× 157 1.5× 225 2.1× 19 515
María E. Sabbatini United States 14 296 1.0× 133 0.6× 202 1.6× 38 0.4× 85 0.8× 26 612
Maria Jimena Amaya United States 11 332 1.2× 144 0.6× 130 1.0× 71 0.7× 44 0.4× 13 624
Ryuichi Murase Japan 12 218 0.8× 183 0.8× 151 1.2× 34 0.3× 69 0.7× 25 671
Claire Rutherford United Kingdom 10 340 1.2× 96 0.4× 105 0.8× 65 0.6× 34 0.3× 23 609
Kokila Chotai United Kingdom 10 366 1.3× 57 0.2× 130 1.0× 199 1.9× 156 1.5× 14 739
Jenny Flygare Sweden 16 393 1.4× 111 0.5× 176 1.4× 27 0.3× 97 0.9× 23 764
Caroline Améen Sweden 13 415 1.4× 167 0.7× 43 0.3× 104 1.0× 72 0.7× 14 674
Joshua Cutts United States 11 215 0.7× 249 1.0× 44 0.3× 22 0.2× 68 0.6× 15 565

Countries citing papers authored by F. Clémente

Since Specialization
Citations

This map shows the geographic impact of F. Clémente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Clémente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Clémente more than expected).

Fields of papers citing papers by F. Clémente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Clémente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Clémente. The network helps show where F. Clémente may publish in the future.

Co-authorship network of co-authors of F. Clémente

This figure shows the co-authorship network connecting the top 25 collaborators of F. Clémente. A scholar is included among the top collaborators of F. Clémente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Clémente. F. Clémente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Estival, A., et al.. (2004). Identification of c‐Jun as a critical mediator for the intracrine 24 kDa FGF‐2 isoform‐induced cell proliferation. International Journal of Cancer. 114(6). 863–869. 13 indexed citations
2.
Ferjoux, Géraldine, A. Estival, Stefan Schulz, et al.. (2003). Inhibitory Role of the Somatostatin Receptor SST2 on the Intracrine-regulated Cell Proliferation Induced by the 210-Amino Acid Fibroblast Growth Factor-2 Isoform. Journal of Biological Chemistry. 278(23). 20574–20581. 25 indexed citations
3.
Gaubert, F., Fabrice Escaffit, Murray Korc, et al.. (2001). Expression of the High Molecular Weight Fibroblast Growth Factor-2 Isoform of 210 Amino Acids Is Associated with Modulation of Protein Kinases C δ and ε and ERK Activation. Journal of Biological Chemistry. 276(2). 1545–1554. 26 indexed citations
5.
Huërou‐Luron, Isabelle Le, Marlène Dufresne, A. Estival, et al.. (1999). The CCKB/gastrin receptor is coupled to the regulation of enzyme secretion, protein synthesis and p70 S6 kinase activity in acinar cells from ElasCCKB transgenic mice. European Journal of Biochemistry. 266(3). 1003–1010. 15 indexed citations
6.
Estival, A., Karine Miquel, F. Gaubert, et al.. (1996). Differential Regulation of Fibroblast Growth Factor (FGF) Receptor-1 mRNA and Protein by Two Molecular Forms of Basic FGF. Journal of Biological Chemistry. 271(10). 5663–5670. 42 indexed citations
7.
Estival, A., Pascal Clerc, Nicole Vaysse, James P. Tam, & F. Clémente. (1992). Decreased expression of transforming growth factor α during differentiation of human pancreatic cancer cells. Gastroenterology. 103(6). 1851–1859. 15 indexed citations
8.
Clerc, Pascal, et al.. (1991). Lipid-dependent proliferation of pancreatic cancer cell lines.. PubMed. 51(14). 3633–8. 30 indexed citations
9.
Estival, A., et al.. (1990). Two subclasses of EGF receptors in the human pancreatic cancer cell lines CAPAN-1 and MIA PaCa-2. International Journal of Pancreatology. 6(2). 119–28. 7 indexed citations
10.
Clémente, F., et al.. (1989). Modulation of enzymatic activities during spontaneous and induced differentiation in a human pancreatic adenocarcinoma cell line CAPAN-1. International Journal of Pancreatology. 4(4). 391–406. 10 indexed citations
11.
Durand, Sylvère, Anna Estival, Claude Vieu, F. Clémente, & Louis Douste‐Blazy. (1987). Lipid Content of Human and Rat Pancreas. Pancreas. 2(3). 326–332. 11 indexed citations
12.
Scemama, J.L., et al.. (1985). VIP regulation of a human pancreatic cancer cell line. Regulatory Peptides. 10. S48–S48. 1 indexed citations
13.
Clerc, Pascal, et al.. (1984). Comparison of immunoreactive components secreted by a human-somatostatinoma and its cultured cells. Journal of Steroid Biochemistry. 20(6). 1614–1614. 1 indexed citations
14.
Estival, A., et al.. (1983). Presence of VIP receptors in a human pancreatic adenocarcinoma cell line. Modulation of the cAMP response during cell proliferation. Biochemical and Biophysical Research Communications. 111(3). 958–963. 29 indexed citations
15.
Estival, A., et al.. (1982). The decrease of the non secretory phospholipase A in rat pancreas during a chronic alcohol intoxication.. PubMed. 36(5). 254–6. 2 indexed citations
16.
Estival, A., F. Clémente, & A Ribet. (1981). Ethanol metabolism by the rat pancreas. Toxicology and Applied Pharmacology. 61(2). 155–165. 44 indexed citations
17.
Clémente, F., et al.. (1979). A lipase with high phospholipase activity in guinea pig pancreatic juice. Biochimie. 60(10). 1215–1217. 14 indexed citations
18.
Clémente, F., Alain De, & Catherine Figarella. (1972). Composition du suc pancréatique humain. European Journal of Biochemistry. 31(1). 186–193. 35 indexed citations
19.
Clémente, F., et al.. (1971). Albumine, igg et iga dans le suc pancréatique humain normal chez l'adulte. Clinica Chimica Acta. 33(2). 317–324. 25 indexed citations
20.
Figarella, Catherine, F. Clémente, & Odette Guy. (1971). A zymogen of phospholipase A in human pancreatic juice. Biochimica et Biophysica Acta (BBA) - Enzymology. 227(1). 213–217. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026